Bruker (BRKR) EPS (Weighted Average and Diluted) Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Bruker | 8.89 Bn | 8.77 Bn | 379.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -44.21% |
| Dec 31, 2025 | -25.98% |
| Sep 30, 2025 | -25.97% |
| Jun 30, 2025 | -20.76% |
| Mar 31, 2025 | 9.46% |
| Dec 31, 2024 | -27.20% |
| Sep 30, 2024 | -7.09% |
| Jun 30, 2024 | -26.30% |
| Mar 31, 2024 | 11.84% |
| Dec 31, 2023 | 22.87% |
| Sep 30, 2023 | 16.47% |
| Jun 30, 2023 | 14.29% |
| Mar 31, 2023 | 25.06% |
| Dec 31, 2022 | 103.62% |
| Sep 30, 2022 | 20.73% |
| Jun 30, 2022 | 17.08% |
| Mar 31, 2022 | 25.83% |
| Dec 31, 2021 | 2.65% |
| Sep 30, 2021 | 14.47% |
| Jun 30, 2021 | 33.39% |
| Mar 31, 2021 | 21.45% |
| Dec 31, 2020 | 4.56% |
| Sep 30, 2020 | 37.97% |
| Jun 30, 2020 | 4.24% |
| Mar 31, 2020 | 11.84% |
| Dec 31, 2019 | 24.01% |
| Sep 30, 2019 | 67.03% |
| Jun 30, 2019 | 18.13% |
| Mar 31, 2019 | 31.95% |
| Dec 31, 2018 | 18.95% |
| Sep 30, 2018 | 22.87% |
| Jun 30, 2018 | 7.39% |
| Mar 31, 2018 | 41.47% |
| Dec 31, 2017 | -17.61% |
| Sep 30, 2017 | -0.85% |
| Jun 30, 2017 | 20.11% |
| Mar 31, 2017 | 7.63% |
| Dec 31, 2016 | 13.33% |
| Sep 30, 2016 | 19.30% |
| Jun 30, 2016 | -7.09% |
| Mar 31, 2016 | 14.87% |
| Dec 31, 2015 | 14.87% |
| Sep 30, 2015 | -16.26% |
| Jun 30, 2015 | -1.47% |
| Mar 31, 2015 | -16.74% |